CIDARA THERAPEUTICS, INC. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a52ce6d4-fc37-4c87-9c0e-31ee8a6b677e/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-176.1M | 2024-01-01 – 2024-12-31 | evidence 0001610618-25-000017 |
| FY 2023 | $-27.1M | 2023-01-01 – 2023-12-31 | evidence 0001610618-25-000017 |
| FY 2022 | $-33.5M | 2022-01-01 – 2022-12-31 | evidence 0001610618-24-000041 |
| FY 2021 | $-42.3M | 2021-01-01 – 2021-12-31 | evidence 0001610618-22-000007 |
| FY 2020 | $-71.8M | 2020-01-01 – 2020-12-31 | evidence 0001610618-21-000008 |
| FY 2019 | $-41.7M | 2019-01-01 – 2019-12-31 | evidence 0001610618-20-000011 |
| FY 2018 | $-63.3M | 2018-01-01 – 2018-12-31 | evidence 0001610618-19-000012 |
| FY 2017 | $-55.7M | 2017-01-01 – 2017-12-31 | evidence 0001610618-18-000011 |
| FY 2016 | $-48.4M | 2016-01-01 – 2016-12-31 | evidence 0001610618-17-000013 |
| FY 2015 | $-32.3M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-015007 |
| FY 2014 | $-11.6M | 2014-01-01 – 2014-12-31 | evidence 0001564590-16-015007 |
| FY 2013 | $-1.1M | 2013-01-01 – 2013-12-31 | evidence 0001564590-16-015007 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CIDARA THERAPEUTICS, INC. — all facts · Revenue · Net Income